nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemfibrozil—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.623	1	CbGbCtD
Gemfibrozil—Peripheral vascular disorder—Riluzole—amyotrophic lateral sclerosis	0.0156	0.0452	CcSEcCtD
Gemfibrozil—Cerebral haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0138	0.04	CcSEcCtD
Gemfibrozil—Cholecystitis—Riluzole—amyotrophic lateral sclerosis	0.0133	0.0386	CcSEcCtD
Gemfibrozil—Myasthenia—Riluzole—amyotrophic lateral sclerosis	0.0122	0.0352	CcSEcCtD
Gemfibrozil—Blood creatine phosphokinase increased—Riluzole—amyotrophic lateral sclerosis	0.0111	0.0322	CcSEcCtD
Gemfibrozil—Neuritis—Riluzole—amyotrophic lateral sclerosis	0.0102	0.0297	CcSEcCtD
Gemfibrozil—Gout—Riluzole—amyotrophic lateral sclerosis	0.00818	0.0237	CcSEcCtD
Gemfibrozil—Blood bilirubin increased—Riluzole—amyotrophic lateral sclerosis	0.00808	0.0234	CcSEcCtD
Gemfibrozil—Cataract—Riluzole—amyotrophic lateral sclerosis	0.00803	0.0233	CcSEcCtD
Gemfibrozil—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.00764	0.0222	CcSEcCtD
Gemfibrozil—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.00638	0.0185	CcSEcCtD
Gemfibrozil—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.00632	0.0183	CcSEcCtD
Gemfibrozil—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00617	0.0179	CcSEcCtD
Gemfibrozil—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.00598	0.0173	CcSEcCtD
Gemfibrozil—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.00588	0.017	CcSEcCtD
Gemfibrozil—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00585	0.017	CcSEcCtD
Gemfibrozil—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.0055	0.016	CcSEcCtD
Gemfibrozil—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00512	0.0148	CcSEcCtD
Gemfibrozil—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00501	0.0145	CcSEcCtD
Gemfibrozil—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00489	0.0142	CcSEcCtD
Gemfibrozil—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.0047	0.0136	CcSEcCtD
Gemfibrozil—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00455	0.0132	CcSEcCtD
Gemfibrozil—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00441	0.0128	CcSEcCtD
Gemfibrozil—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00438	0.0127	CcSEcCtD
Gemfibrozil—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00434	0.0126	CcSEcCtD
Gemfibrozil—Depression—Riluzole—amyotrophic lateral sclerosis	0.00426	0.0124	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00419	0.0121	CcSEcCtD
Gemfibrozil—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00417	0.0121	CcSEcCtD
Gemfibrozil—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00415	0.012	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00404	0.0117	CcSEcCtD
Gemfibrozil—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00385	0.0112	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00382	0.0111	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00377	0.0109	CcSEcCtD
Gemfibrozil—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00359	0.0104	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00346	0.01	CcSEcCtD
Gemfibrozil—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00339	0.00983	CcSEcCtD
Gemfibrozil—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00336	0.00975	CcSEcCtD
Gemfibrozil—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00329	0.00954	CcSEcCtD
Gemfibrozil—Tension—Riluzole—amyotrophic lateral sclerosis	0.00328	0.0095	CcSEcCtD
Gemfibrozil—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00327	0.00948	CcSEcCtD
Gemfibrozil—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00324	0.00941	CcSEcCtD
Gemfibrozil—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00309	0.00895	CcSEcCtD
Gemfibrozil—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00305	0.00885	CcSEcCtD
Gemfibrozil—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.003	0.0087	CcSEcCtD
Gemfibrozil—Syncope—Riluzole—amyotrophic lateral sclerosis	0.003	0.00869	CcSEcCtD
Gemfibrozil—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00299	0.00867	CcSEcCtD
Gemfibrozil—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00294	0.00851	CcSEcCtD
Gemfibrozil—Cough—Riluzole—amyotrophic lateral sclerosis	0.00291	0.00845	CcSEcCtD
Gemfibrozil—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00289	0.00839	CcSEcCtD
Gemfibrozil—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00284	0.00825	CcSEcCtD
Gemfibrozil—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00284	0.00825	CcSEcCtD
Gemfibrozil—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00284	0.00825	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00282	0.00819	CcSEcCtD
Gemfibrozil—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00275	0.00797	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00273	0.0079	CcSEcCtD
Gemfibrozil—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00273	0.0079	CcSEcCtD
Gemfibrozil—Shock—Riluzole—amyotrophic lateral sclerosis	0.00268	0.00778	CcSEcCtD
Gemfibrozil—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00267	0.00775	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00267	0.00774	CcSEcCtD
Gemfibrozil—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00265	0.00768	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00248	0.0072	CcSEcCtD
Gemfibrozil—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00245	0.0071	CcSEcCtD
Gemfibrozil—PPARA—RXR and RAR heterodimerization with other nuclear receptor—RARA—amyotrophic lateral sclerosis	0.00243	0.075	CbGpPWpGaD
Gemfibrozil—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00242	0.00703	CcSEcCtD
Gemfibrozil—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.0024	0.00696	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00235	0.00682	CcSEcCtD
Gemfibrozil—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00235	0.00681	CcSEcCtD
Gemfibrozil—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00233	0.00676	CcSEcCtD
Gemfibrozil—Pain—Riluzole—amyotrophic lateral sclerosis	0.00233	0.00676	CcSEcCtD
Gemfibrozil—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00225	0.00651	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00223	0.00646	CcSEcCtD
Gemfibrozil—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00217	0.00628	CcSEcCtD
Gemfibrozil—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00215	0.00625	CcSEcCtD
Gemfibrozil—PPARA—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00196	0.0605	CbGpPWpGaD
Gemfibrozil—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00196	0.00567	CcSEcCtD
Gemfibrozil—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00193	0.00559	CcSEcCtD
Gemfibrozil—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00187	0.00541	CcSEcCtD
Gemfibrozil—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.0018	0.00523	CcSEcCtD
Gemfibrozil—PPARA—Nuclear Receptors—RARA—amyotrophic lateral sclerosis	0.0018	0.0554	CbGpPWpGaD
Gemfibrozil—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00173	0.00503	CcSEcCtD
Gemfibrozil—Rash—Riluzole—amyotrophic lateral sclerosis	0.00172	0.00498	CcSEcCtD
Gemfibrozil—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00172	0.00498	CcSEcCtD
Gemfibrozil—Headache—Riluzole—amyotrophic lateral sclerosis	0.00171	0.00495	CcSEcCtD
Gemfibrozil—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00162	0.00469	CcSEcCtD
Gemfibrozil—PPARA—Nuclear Receptor transcription pathway—RARA—amyotrophic lateral sclerosis	0.00142	0.0437	CbGpPWpGaD
Gemfibrozil—PPARA—Organelle biogenesis and maintenance—GFM1—amyotrophic lateral sclerosis	0.00131	0.0405	CbGpPWpGaD
Gemfibrozil—PPARA—Circadian rythm related genes—SETX—amyotrophic lateral sclerosis	0.00119	0.0367	CbGpPWpGaD
Gemfibrozil—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—amyotrophic lateral sclerosis	0.000958	0.0295	CbGpPWpGaD
Gemfibrozil—CYP2C19—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.000792	0.0244	CbGpPWpGaD
Gemfibrozil—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—amyotrophic lateral sclerosis	0.000779	0.024	CbGpPWpGaD
Gemfibrozil—PPARA—Adipogenesis—RARA—amyotrophic lateral sclerosis	0.000671	0.0207	CbGpPWpGaD
Gemfibrozil—CYP1A2—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.000617	0.019	CbGpPWpGaD
Gemfibrozil—PPARA—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.000616	0.019	CbGpPWpGaD
Gemfibrozil—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000518	0.016	CbGpPWpGaD
Gemfibrozil—PPARA—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.000467	0.0144	CbGpPWpGaD
Gemfibrozil—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000443	0.0136	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000392	0.0121	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000359	0.0111	CbGpPWpGaD
Gemfibrozil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000342	0.0105	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000334	0.0103	CbGpPWpGaD
Gemfibrozil—PPARA—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	0.000316	0.00974	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000314	0.00967	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.000296	0.00914	CbGpPWpGaD
Gemfibrozil—PPARA—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000283	0.00871	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.000252	0.00777	CbGpPWpGaD
Gemfibrozil—PPARA—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.000245	0.00756	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.000225	0.00693	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000221	0.00682	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000215	0.00662	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—PFN1—amyotrophic lateral sclerosis	0.000208	0.0064	CbGpPWpGaD
Gemfibrozil—CYP2C19—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.000207	0.00639	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000202	0.00624	CbGpPWpGaD
Gemfibrozil—SLCO1B1—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000202	0.00624	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000188	0.0058	CbGpPWpGaD
Gemfibrozil—CYP2C8—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000183	0.00563	CbGpPWpGaD
Gemfibrozil—PPARA—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000182	0.00561	CbGpPWpGaD
Gemfibrozil—PPARA—Adipogenesis—IGF1—amyotrophic lateral sclerosis	0.000178	0.00549	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000177	0.00545	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000175	0.00538	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000175	0.00538	CbGpPWpGaD
Gemfibrozil—SLCO1B1—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000172	0.0053	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000165	0.00509	CbGpPWpGaD
Gemfibrozil—CYP2C19—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000163	0.00502	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000163	0.00502	CbGpPWpGaD
Gemfibrozil—CYP1A2—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.000162	0.00498	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00016	0.00492	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00016	0.00492	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.000156	0.0048	CbGpPWpGaD
Gemfibrozil—PPARA—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000155	0.00477	CbGpPWpGaD
Gemfibrozil—PPARA—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000155	0.00477	CbGpPWpGaD
Gemfibrozil—SLCO1B1—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000153	0.00473	CbGpPWpGaD
Gemfibrozil—CYP2C9—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000149	0.00458	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000149	0.00458	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000147	0.00455	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000145	0.00446	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.00014	0.00432	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00014	0.0043	CbGpPWpGaD
Gemfibrozil—PPARA—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000138	0.00426	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000134	0.00414	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000127	0.00392	CbGpPWpGaD
Gemfibrozil—CYP1A2—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000127	0.00391	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—DAO—amyotrophic lateral sclerosis	0.000126	0.00389	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000121	0.00374	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—RARA—amyotrophic lateral sclerosis	0.000118	0.00364	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000116	0.00359	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000115	0.00354	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000114	0.0035	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000108	0.00333	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000104	0.0032	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000104	0.00319	CbGpPWpGaD
Gemfibrozil—CYP2C8—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000103	0.00317	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000103	0.00317	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000102	0.00313	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—TPK1—amyotrophic lateral sclerosis	9.86e-05	0.00304	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—VAPB—amyotrophic lateral sclerosis	9.86e-05	0.00304	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	9.66e-05	0.00298	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PLB1—amyotrophic lateral sclerosis	9.57e-05	0.00295	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	9.47e-05	0.00292	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	9.19e-05	0.00283	CbGpPWpGaD
Gemfibrozil—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	9.19e-05	0.00283	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	9.08e-05	0.0028	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—VAPA—amyotrophic lateral sclerosis	9.02e-05	0.00278	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	8.87e-05	0.00273	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	8.85e-05	0.00273	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—GSR—amyotrophic lateral sclerosis	8.84e-05	0.00272	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	8.8e-05	0.00271	CbGpPWpGaD
Gemfibrozil—CYP1A2—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	8.79e-05	0.00271	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	8.74e-05	0.00269	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	8.74e-05	0.00269	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.38e-05	0.00258	CbGpPWpGaD
Gemfibrozil—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	8.38e-05	0.00258	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	8.28e-05	0.00255	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	8.09e-05	0.00249	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	8.05e-05	0.00248	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—FIG4—amyotrophic lateral sclerosis	7.88e-05	0.00243	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	7.79e-05	0.0024	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	7.65e-05	0.00236	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	7.52e-05	0.00232	CbGpPWpGaD
Gemfibrozil—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	7.39e-05	0.00228	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	7.29e-05	0.00225	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—CHAT—amyotrophic lateral sclerosis	7.26e-05	0.00224	CbGpPWpGaD
Gemfibrozil—CYP1A2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	7.16e-05	0.00221	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—DAO—amyotrophic lateral sclerosis	7.13e-05	0.0022	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	7.07e-05	0.00218	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	6.97e-05	0.00215	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	6.62e-05	0.00204	CbGpPWpGaD
Gemfibrozil—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	6.6e-05	0.00203	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	6.51e-05	0.00201	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	6.22e-05	0.00192	CbGpPWpGaD
Gemfibrozil—PPARA—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	6.21e-05	0.00191	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	6.03e-05	0.00186	CbGpPWpGaD
Gemfibrozil—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	6.02e-05	0.00185	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	5.94e-05	0.00183	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	5.67e-05	0.00175	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	5.67e-05	0.00175	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	5.67e-05	0.00175	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PLB1—amyotrophic lateral sclerosis	5.4e-05	0.00166	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	5.28e-05	0.00163	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	5.18e-05	0.0016	CbGpPWpGaD
Gemfibrozil—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	5.14e-05	0.00158	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	5.07e-05	0.00156	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	5.06e-05	0.00156	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	5.06e-05	0.00156	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—GSR—amyotrophic lateral sclerosis	4.99e-05	0.00154	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	4.85e-05	0.00149	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.82e-05	0.00148	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	4.72e-05	0.00145	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	4.63e-05	0.00143	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	4.61e-05	0.00142	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	4.61e-05	0.00142	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.54e-05	0.0014	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.54e-05	0.0014	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	4.53e-05	0.0014	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—MMP9—amyotrophic lateral sclerosis	4.46e-05	0.00137	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.3e-05	0.00133	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	4.3e-05	0.00133	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	4.22e-05	0.0013	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	4.1e-05	0.00126	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—CHAT—amyotrophic lateral sclerosis	4.09e-05	0.00126	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	4.04e-05	0.00125	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	4e-05	0.00123	CbGpPWpGaD
Gemfibrozil—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.97e-05	0.00122	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	3.94e-05	0.00121	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	3.94e-05	0.00121	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.92e-05	0.00121	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.91e-05	0.00121	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.9e-05	0.0012	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.74e-05	0.00115	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	3.69e-05	0.00114	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	3.67e-05	0.00113	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	3.66e-05	0.00113	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	3.6e-05	0.00111	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.58e-05	0.0011	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.35e-05	0.00103	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	3.33e-05	0.00103	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	3.15e-05	0.000971	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	3.1e-05	0.000957	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	3.04e-05	0.000937	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	3.04e-05	0.000937	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—APOE—amyotrophic lateral sclerosis	2.95e-05	0.000909	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	2.86e-05	0.000883	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	2.85e-05	0.000878	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	2.78e-05	0.000857	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	2.77e-05	0.000854	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.61e-05	0.000804	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.59e-05	0.000797	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.56e-05	0.000789	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	2.56e-05	0.000788	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	2.53e-05	0.000779	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	2.43e-05	0.000749	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	2.35e-05	0.000725	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	2.33e-05	0.000719	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.33e-05	0.000718	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.2e-05	0.000678	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	2.2e-05	0.000678	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	2.16e-05	0.000665	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.15e-05	0.000662	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.12e-05	0.000654	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	2.1e-05	0.000647	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.02e-05	0.000623	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.02e-05	0.000623	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	1.99e-05	0.000614	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.92e-05	0.000591	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	1.91e-05	0.00059	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.81e-05	0.000559	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.75e-05	0.000538	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	1.67e-05	0.000514	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—APOE—amyotrophic lateral sclerosis	1.66e-05	0.000513	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.64e-05	0.000504	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	1.54e-05	0.000474	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.49e-05	0.00046	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.47e-05	0.000453	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.31e-05	0.000405	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.26e-05	0.00039	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	1.26e-05	0.000389	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.2e-05	0.000369	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.16e-05	0.000358	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.14e-05	0.000351	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.13e-05	0.000348	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.04e-05	0.00032	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.03e-05	0.000317	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.02e-05	0.000315	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	9.56e-06	0.000295	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.46e-06	0.000291	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.79e-06	0.000271	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	8.53e-06	0.000263	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.08e-06	0.000249	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	7.78e-06	0.00024	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.79e-06	0.000209	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	6.65e-06	0.000205	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.55e-06	0.000202	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.24e-06	0.000192	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.85e-06	0.00018	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.33e-06	0.000164	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	5.13e-06	0.000158	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.56e-06	0.00014	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.52e-06	0.000108	CbGpPWpGaD
